Cipla share price
You have to be logged in to add this to Watchlist.- ₹1,314.85(-4.13%)January 23, 2026 15:40:15 PM IST
- NSE
- BSE
- Vol : 7.12 M (NSE + BSE)Last 20 day avg : 2.34 M
Cipla is trading -4.13% lower at Rs 1,314.85 as compared to its last closing price. Cipla has been trading in the price range of 1,385.95 & 1,303.80. Cipla has given -9.32% in this year & -4.47% in the last 5 days. Cipla has TTM P/E ratio 22.31 as compared to the sector P/E of 22.37.There are 36 analysts who have initiated coverage on Cipla. There are 7 analysts who have given it a strong buy rating & 14 analysts have given it a buy rating. 6 analysts have given the stock a sell rating.The company posted a net profit of 675.80 Crores in its last quarter.Listed peers of Cipla include Torrent Pharmaceuticals (-2.48%), Sun Pharmaceutical Industries (-0.24%), Lupin (-1.29%).The Mutual Fund holding in Cipla was at 19.21% in 31 Dec 2025. The MF holding has decreased from the last quarter. The FII holding in Cipla was at 23.93% in 31 Dec 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Jan 25, 2026, 10:11 AM UTC
- BetaLow volatility0.49Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.01The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldInline with the industry0.95Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation0.73The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals | Neutral | 3,924.15 | -2.48 | 1,32,927.95 | 67.32 | 17.1 | 0.83 | 17.62 |
| Sun Pharmaceutical Industries | Bearish | 1,630.45 | -0.24 | 3,91,070.72 | 36.24 | 5.77 | 0.92 | 0.50 |
| Lupin | Neutral | 2,137.15 | -1.29 | 97,613.49 | 28.78 | 5.59 | 0.57 | 11.80 |
| Dr Reddy's Laboratories | Neutral | 1,235.15 | 1.48 | 1,03,084.54 | 18.63 | 3.14 | 0.63 | 2.34 |
| Divi's Laboratories | Bearish | 6,007.00 | -1.08 | 1,59,244.08 | 78.61 | 11.52 | 0.46 | 0.01 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-01-23 | Quarterly Results |
| 2025-10-30 | Quarterly Results |
| 2025-07-25 | Quarterly Results |
| 2025-05-13 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE059A01026
- BSE Code500087
- NSE CodeCIPLA
Cipla is trading at 1314.85 as on Fri Jan 23 2026 10:10:15. This is -4.13% lower as compared to its previous closing price of 1371.55.
The market capitalization of Cipla is 106175.04 Cr as on Fri Jan 23 2026 10:10:15.
The average broker rating on Cipla is Buy. The breakup of analyst rating is given below -
- 7 analysts have given a strong buy rating
- 14 analysts have given a buy rating
- 9 analysts have given a hold rating
- 6 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Cipla is 1672.20 whereas the 52 wk low is 1307.45
Cipla can be analyzed on the following key metrics -
- TTM P/E: 22.31
- Sector P/E: 22.37
- Dividend Yield: 0.95%
- D/E ratio: 0.01
Cipla reported a net profit of 5272.52 Cr in 2025.
The Mutual Fund Shareholding was 19.21% at the end of 31 Dec 2025.
EQUITY QUICK LINKS
Cipla QUICK LINKS
FROM MARKETS
RELATED LINKS
Quarterly Results
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.